| James Shira, MD | |
|
13123 E 16th Ave, Aurora, CO 80045-7106 | |
| (720) 777-1234 | |
| Not Available |
| Full Name | James Shira |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Allergy/immunology |
| Location | 13123 E 16th Ave, Aurora, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194800821 | NPI | - | NPPES |
| 01179118 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0201X | Pediatrics - Pediatric Allergy/immunology | 17911 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James Shira, MD Po Box 110429, Aurora, CO 80042-0429 Ph: (303) 493-7000 | James Shira, MD 13123 E 16th Ave, Aurora, CO 80045-7106 Ph: (720) 777-1234 |
News Archive
Congenital heart defects are the most common type of major birth defects in the U.S., affecting about 34,000 babies each year. Twenty percent of these patients are born with a malformation of the pulmonary valve, which is a flap-like opening on the right side of the heart that is responsible for regulating the blood flow to the lungs. Now, a new replacement valve being used at Rush University Medical Center can help patients with damaged heart valves delay or avoid multiple open-heart surgeries.
A $2 million phase 2 Small Business Technology Transfer grant to optimize a promising new compound that has shown efficacy in preclinical studies against treatment-resistant multiple myeloma has been awarded to a Medical University of South Carolina startup company, Leukogene Therapeutics, Inc., in collaboration with MUSC researcher and company founder, Nathan G. Dolloff, Ph.D. Dolloff is an assistant professor in the Department of Cell and Molecular Pharmacology & Experimental Therapeutics at MUSC and a member of MUSC Hollings Cancer Center.
Despite the increasing awareness of the problem of obesity in the United States, most Americans don't know whether they are gaining or losing weight, according to new research from the Institute for Health Metrics and Evaluation at the University of Washington.
Intercept Pharmaceuticals, Inc., has been informed by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health that patient enrollment has started in a new clinical trial in patients with nonalcoholic steatohepatitis, which will evaluate Intercept's first-in-class farnesoid X receptor agonist obeticholic acid as a novel therapy for NASH.
› Verified 6 days ago
Dr. Jonathan Orsborn, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Dr. Joel A. Friedlander, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 Fax: 720-777-7277 | |
Dr. Emily Greenwald, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Children's Hospital Colorado, Aurora, CO 80045 Phone: 720-777-1234 | |
Jessica Boat Landry, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Robert Kramer, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Richard W. Penland, Pediatrics Medicare: Medicare Enrolled Practice Location: 1501 S Potomac St, Aurora, CO 80012 Phone: 303-695-2628 Fax: 303-306-7753 | |
John Roger Hollister, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 |